tiprankstipranks
Ascendis Pharma A/S (ASND)
NASDAQ:ASND
US Market
ASND
Ascendis Pharma
RESEARCH TOOLSreports
Want to see ASND full AI Analyst Report?

Ascendis Pharma (ASND) Ratios

700 Followers

Ascendis Pharma Ratios

ASND's free cash flow for Q1 2026 was €0.91. For the 2026 fiscal year, ASND's free cash flow was decreased by € and operating cash flow was €0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.00 1.04 1.17 0.95 1.29
Quick Ratio
 0.72 0.76 0.84 0.67 1.11
Cash Ratio
 0.51 0.58 0.62 0.53 0.62
Solvency Ratio
 0.35 -0.14 -0.28 -0.48 -0.68
Operating Cash Flow Ratio
 0.05 0.05 -0.34 -0.63 -0.69
Short-Term Operating Cash Flow Coverage
 0.11 0.11 -0.62 -1.11 -1.20
Net Current Asset Value
€ -393.38M€ -356.25M€ -224.34M€ -268.56M€ 97.08M
Leverage Ratios
Debt-to-Assets Ratio
 0.45 0.67 0.73 0.90 0.57
Debt-to-Equity Ratio
 1.84 -5.35 -8.10 -5.10 2.35
Debt-to-Capital Ratio
 0.65 1.23 1.14 1.24 0.70
Long-Term Debt-to-Capital Ratio
 0.44 1.73 1.41 2.88 0.27
Financial Leverage Ratio
 4.11 -8.00 -11.16 -5.67 4.14
Debt Service Coverage Ratio
 0.96 -0.23 -0.53 -0.90 -1.20
Interest Coverage Ratio
 -0.04 -1.69 -4.26 -10.34 -18.31
Debt to Market Cap
 0.08 0.08 0.11 0.10 0.08
Interest Debt Per Share
 17.51 15.66 15.93 13.98 11.56
Net Debt to EBITDA
 -46.69 -2.24 -1.02 -0.85 -0.33
Profitability Margins
Gross Profit Margin
88.17%85.08%87.83%83.36%76.28%
EBIT Margin
-2.81%-18.92%-84.63%-161.25%-1069.17%
EBITDA Margin
-0.80%-16.47%-79.76%-154.16%-1034.07%
Operating Profit Margin
-0.80%-18.92%-76.66%-170.79%-1097.85%
Pretax Profit Margin
-19.34%-29.53%-102.64%-177.77%-1129.12%
Net Profit Margin
58.40%-31.67%-103.97%-180.51%-1139.63%
Continuous Operations Profit Margin
58.40%-31.67%-103.97%-180.51%-1139.63%
Net Income Per EBT
-301.90%107.23%101.30%101.54%100.93%
EBT Per EBIT
2421.13%156.05%133.89%104.08%102.85%
Return on Assets (ROA)
25.26%-16.82%-32.05%-58.32%-53.52%
Return on Equity (ROE)
-5641.90%134.58%357.68%330.44%-221.45%
Return on Capital Employed (ROCE)
-0.79%-56.16%-102.63%-511.40%-150.64%
Return on Invested Capital (ROIC)
1.51%-18.19%-36.53%-86.85%-70.25%
Return on Tangible Assets
25.31%-16.87%-32.16%-58.63%-53.76%
Earnings Yield
4.27%-1.99%-4.91%-7.51%-9.12%
Efficiency Ratios
Receivables Turnover
 4.41 4.39 2.19 7.43 4.30
Payables Turnover
 1.30 1.14 0.46 0.47 0.12
Inventory Turnover
 0.33 0.34 0.15 0.21 0.09
Fixed Asset Turnover
 6.38 4.72 3.68 2.41 0.40
Asset Turnover
 0.43 0.53 0.31 0.32 0.05
Working Capital Turnover Ratio
 49.36 7.18 6.10 3.09 0.11
Cash Conversion Cycle
 922.19 828.84 1.81K 989.36 976.35
Days of Sales Outstanding
 82.81 83.18 166.90 49.09 84.95
Days of Inventory Outstanding
 1.12K 1.07K 2.44K 1.72K 3.93K
Days of Payables Outstanding
 279.80 320.56 794.97 777.49 3.04K
Operating Cycle
 1.20K 1.15K 2.60K 1.77K 4.01K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.93 0.85 -5.29 -8.30 -8.84
Free Cash Flow Per Share
 0.68 0.72 -5.31 -8.35 -9.10
CapEx Per Share
 0.25 0.13 0.02 0.04 0.26
Free Cash Flow to Operating Cash Flow
 0.73 0.84 1.00 1.01 1.03
Dividend Paid and CapEx Coverage Ratio
 3.71 6.35 -214.57 -191.38 -34.21
Capital Expenditure Coverage Ratio
 3.71 6.35 -214.57 -191.38 -34.21
Operating Cash Flow Coverage Ratio
 0.06 0.06 -0.36 -0.63 -0.80
Operating Cash Flow to Sales Ratio
 0.07 0.07 -0.84 -1.75 -9.69
Free Cash Flow Yield
0.35%0.40%-4.00%-7.32%-7.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 23.42 -50.22 -20.36 -13.32 -10.97
Price-to-Sales (P/S) Ratio
 13.70 15.90 21.17 24.05 124.97
Price-to-Book (P/B) Ratio
 24.29 -67.58 -72.81 -44.02 24.28
Price-to-Free Cash Flow (P/FCF) Ratio
 282.25 252.17 -25.02 -13.65 -12.54
Price-to-Operating Cash Flow Ratio
 205.89 212.47 -25.14 -13.72 -12.90
Price-to-Earnings Growth (PEG) Ratio
 0.05 1.13 0.86 0.75 -0.23
Price-to-Fair Value
 24.29 -67.58 -72.81 -44.02 24.28
Enterprise Value Multiple
 -1.76K -98.82 -27.56 -16.45 -12.41
Enterprise Value
 12.20B 11.26B 7.99B 6.76B 6.57B
EV to EBITDA
 -1.76K -98.82 -27.56 -16.45 -12.41
EV to Sales
 14.06 16.27 21.98 25.36 128.35
EV to Free Cash Flow
 289.67 258.03 -25.99 -14.40 -12.87
EV to Operating Cash Flow
 211.64 217.41 -26.11 -14.47 -13.25
Tangible Book Value Per Share
 7.86 -2.75 -1.90 -2.67 4.61
Shareholders’ Equity Per Share
 7.92 -2.69 -1.83 -2.59 4.70
Tax and Other Ratios
Effective Tax Rate
 4.02 -0.07 -0.01 -0.02 >-0.01
Revenue Per Share
 14.06 11.41 6.28 4.74 0.91
Net Income Per Share
 8.21 -3.61 -6.53 -8.55 -10.40
Tax Burden
 -3.02 1.07 1.01 1.02 1.01
Interest Burden
 6.89 1.56 1.21 1.10 1.06
Research & Development to Revenue
 0.31 0.41 0.84 1.55 7.42
SG&A to Revenue
 0.57 0.63 0.78 0.97 4.22
Stock-Based Compensation to Revenue
 0.07 0.00 0.26 0.25 1.25
Income Quality
 0.11 -0.24 0.81 0.97 0.85
Currency in EUR